How Proassurance Corporation (PRA) Affects Rotational Strategy Timing
This article analyzes Proassurance Corporation (PRA) with a focus on its impact on rotational strategy timing. It highlights a neutral sentiment across all time horizons, suggesting a wait-and-see approach. The analysis includes AI-generated institutional trading strategies for long, breakout, and short positions, along with multi-timeframe signal analysis and risk-reward ratios for potential trades.
ProAssurance Corporation Common Stock (NY: PRA
This article provides recent news headlines and financial updates for ProAssurance Corporation (NYSE: PRA), including analyst ratings, earnings reports, dividend announcements, and insider filings. It covers news from various sources like Benzinga, The Motley Fool, and Business Wire, primarily focusing on financial performance and corporate actions from late 2022 to mid-2023. The stock is currently trading at 24.51, unchanged as of May 15, 2026.
PRA Technical Analysis & Stock Price Forecast
The technical analysis for Proassurance Corp (PRA) indicates a Neutral overall sentiment as of May 15, 2026. While some momentum indicators like RSI are neutral, MACD and certain moving averages suggest a sell signal for short-term momentum. However, the stock is trading above its 60-day and 200-day moving averages, which can be seen as a long-term bullish sign.
ProAssurance Q1 earnings meet estimates on declining expenses
ProAssurance (PRA) reported its Q1 earnings, meeting estimates primarily due to a reduction in expenses. The company's focus on cost control has positively impacted its financial performance for the quarter. This outcome highlights effective management strategies in lowering operational costs.
Life Insurance In Force of ProAssurance Corporation – NYSE:PRA
This page provides financial data specifically on the "Life Insurance In Force" metric for ProAssurance Corporation (NYSE:PRA). It appears to be a section within a larger financial overview on the TradingView platform. The content primarily lists the company name and stock exchange information, emphasizing its financial performance data accessible via the website.
ProAssurance Q1 Earnings Meet Estimates on Declining Expenses
ProAssurance (PRA) reported Q1 2026 adjusted operating income of 25 cents per share, meeting Zacks Consensus Estimate and increasing from 13 cents last year. Despite a 2.5% dip in operating revenues to $263.1 million, the company benefited from rising investment income and declining expenses, though lower premiums in key segments partially offset gains. Net premiums earned fell by 5.4% year-over-year, but net investment income rose by 8.2%, and total expenses decreased by 9%, leading to a significant 245.3% surge in net income.
ProAssurance (NYSE:PRA) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen has downgraded ProAssurance (NYSE:PRA) from a "hold" to a "sell" rating. Despite this, MarketBeat maintains a consensus "Buy" rating, and Zacks Research recently upgraded the stock to "strong-buy." ProAssurance matched EPS expectations at $0.25, while revenue surpassed forecasts at $262.63 million, and institutional ownership remains high at 85.58%.
ProAssurance (PRA) Margin Improvement Reinforces Bullish Narratives Despite Volatile Quarterly EPS
ProAssurance (PRA) reported Q1 2026 revenue of US$262.6 million and basic EPS of US$0.16, with trailing net profit margins improving to 5.9%. While the company shows improved profitability and five-year annualized earnings growth, there are concerns regarding declining trailing revenue, volatile quarterly EPS, and a premium valuation compared to forecasts of future revenue and earnings declines. Investors are evaluating the tension between recent margin gains and a projected slowdown in growth.
ProAssurance's combined ratio improves to 109.9% in Q1
ProAssurance Corporation reported an increase in Q1 operating income to $12.7 million, or $0.25 per diluted share, up from $6.8 million, or $0.13 per diluted share, a year prior. This improvement was driven by better underwriting results and higher investment income for the medical professional liability insurer. The company is currently in the process of being acquired by The Doctors Company.
Credit Industriel ET Commercial Boosts Holdings in ProAssurance Corporation $PRA
Credit Industriel ET Commercial has significantly increased its stake in ProAssurance Corporation (NYSE:PRA) by 37.5% in the fourth quarter, now owning 346,854 shares valued at approximately $8.38 million. This move makes ProAssurance the 22nd largest holding in their portfolio, representing 0.6% of their investments. The article highlights strong institutional ownership at 85.58% and a consensus "Moderate Buy" rating from analysts with a target price of $25.00, following the company's Q1 earnings which met EPS estimates and exceeded revenue expectations.
ProAssurance (PRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
ProAssurance (PRA) reported its Q1 2026 earnings, with revenues of $263.12 million exceeding the Zacks Consensus Estimate by 2.15%, although representing a 2.5% year-over-year decline. The company's EPS of $0.25 was flat compared to the consensus estimate but higher than the $0.13 reported in the prior year. Key metrics like Underwriting Expense Ratio and Net Premiums Earned outperformed analyst estimates, while Combined Ratio and Net Loss Ratio were slightly above expectations.
ProAssurance (NYSE:PRA) Issues Quarterly Earnings Results
ProAssurance (NYSE:PRA) reported quarterly earnings of $0.25 per share, matching analyst expectations, and revenue of $262.63 million, exceeding estimates despite a 3.5% year-over-year decrease. The company's stock traded flat at $24.66, with analysts offering a "Moderate Buy" consensus rating and a $25 target price. Institutional investors hold 85.58% of the company's stock.
ProAssurance: Q1 Earnings Snapshot
ProAssurance Corp. (PRA) reported a first-quarter net income of $8.5 million, or 16 cents per share, which adjusted to 25 cents per share after non-recurring costs, meeting Wall Street expectations. The medical professional liability insurer also surpassed revenue forecasts, posting $262.6 million in revenue, with an adjusted $263.1 million.
Earnings Flash (PRA) ProAssurance Corporation Reports Q1 Revenue $262.6M
ProAssurance Corporation (PRA) reported its first-quarter revenue of $262.6 million. The specialty insurer, which focuses on healthcare professional liability, medical technology liability, legal professional liability, and workers' compensation insurance, also disclosed its Q1 Adjusted EPS of $0.25 per share, falling short of FactSet's estimate of $0.27. The company's stock closed at $24.66 on May 5th, 2026.
Earnings Flash (PRA) ProAssurance Corporation Posts Q1 Adjusted EPS $0.25 per Share, vs. FactSet Est of $0.27
ProAssurance Corporation (PRA) reported its Q1 adjusted EPS at $0.25 per share, falling short of the FactSet estimate of $0.27 per share. The company operates as a specialty insurer focusing on healthcare professional liability, medical technology, legal professional liability, and workers' compensation insurance. Its segments cover Specialty P&C, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance, and Corporate, with operations spanning approximately 19 U.S. states and Cayman Islands SPCs.
ProAssurance (NYSE: PRA) returns to profit while $25 cash merger progresses
ProAssurance (NYSE: PRA) reported a return to profit in Q1 2026 with a net income of $8.5 million on total revenues of $262.6 million, reversing a prior-year loss. The company's merger with The Doctors Company for $25.00 per share in cash is progressing, having received approvals from several insurance regulators, with California and Pennsylvania reviews still pending. ProAssurance anticipates closing the transaction by June 30, 2026, and its financial performance was positively impacted by net favorable prior-year loss reserve development and increased net investment income.
ProAssurance Reports Results for First Quarter 2026
ProAssurance Corporation reported net income of $8.5 million and operating income of $12.7 million for the first quarter of 2026, driven by improved operating performance and favorable prior year reserve development. The company continues to make progress on premium rate levels and its proposed merger with The Doctors Company, which is subject to regulatory approvals. Consolidated net premiums written for the quarter were $258.6 million, with Specialty P&C renewal premiums increasing by 6%.
Q1 2026 lifts ProAssurance (NYSE: PRA) with higher operating income
ProAssurance reported a significant turnaround in Q1 2026, achieving a net income of $8.5 million and a non-GAAP operating income of $12.7 million, up 86.7% from the previous year. This improvement occurred despite a 3.5% decline in total revenues, largely due to faster reductions in underwriting and loss expenses and a better non-GAAP combined ratio of 109.9%. The company is also progressing with its merger with The Doctors Company, expecting to close by June 30, 2026, pending final regulatory approvals.
ProAssurance (NYSE:PRA) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen has upgraded ProAssurance (NYSE:PRA) from a "sell" to a "hold" rating, contributing to a MarketBeat consensus of a "Moderate Buy" with a $25.00 target price. This upgrade follows strong Q4 results where the company significantly beat EPS expectations. Several institutional investors, including HSBC, also increased their stakes in ProAssurance, reflecting growing investor confidence.
Vanguard Capital Management (PRA) holds 2.619M shares, 5.09% stake
Vanguard Capital Management has reported a 5.09% stake in ProAssurance Corp (PRA), holding 2,619,108 shares of Common Stock. This passive investment was disclosed in a Schedule 13G SEC filing, with 378,233 shares having sole voting power and all 2,619,108 shares having sole dispositive power. The filing indicates a consistent institutional portfolio holding and does not suggest an activist intent.
Vanguard Portfolio Management reports 2.8M ProAssurance holdings (NYSE: PRA)
Vanguard Portfolio Management has reported beneficial ownership of 2,800,643 shares of ProAssurance Corp (NYSE: PRA) common stock, representing 5.44% of the class. This disclosure, made via a Schedule 13G SEC filing, indicates Vanguard's passive investment intentions. The firm holds sole dispositive power over all these shares and sole voting power over 19,636 shares.
ProAssurance (PRA) to Release Earnings on Tuesday
ProAssurance (NYSE:PRA) is scheduled to release its Q1 2026 earnings before market open on Tuesday, May 5th. Analysts anticipate earnings of $0.24 per share and revenue of $213.8460 million. The company's stock was up 0.2% at $24.75, and institutional investors have recently adjusted their holdings in PRA.
Assessing ProAssurance (PRA) Valuation As Recent Returns Put Fair Value In Focus
ProAssurance (PRA) is attracting investor attention due to recent share performance and improved returns, with its market value at approximately US$1.27 billion. The stock's current price of US$24.69 is trading above the fair value estimate of US$22.67, suggesting it is overvalued. Analysts believe future upside hinges on continued margin expansion, disciplined pricing, and successful implementation of strategic initiatives like AI tools.
ProAssurance Shares Move Above Key Average After Earnings Beat
ProAssurance shares have recently moved above a key average after the company reported earnings that exceeded forecasts. While earnings and revenue surpassed expectations, the revenue was lower than the previous year, and mixed sentiments continue to influence the stock. The article highlights that increased trading volume can signify heightened market engagement, particularly during significant movements or in response to new information.
ProAssurance (NYSE:PRA) Stock Price Crosses Above Two Hundred Day Moving Average - Here's Why
ProAssurance (NYSE:PRA) stock price has risen above its 200-day moving average, trading at $24.5840 with a high of $24.60. The company reported strong quarterly earnings of $0.82 EPS, significantly beating consensus estimates, though revenue was down year-over-year. Analysts have mixed views, with an average "Moderate Buy" rating and a $25.00 target price.
Targeting a Low-Profile Alabama-Based Insurer
This article recommends buying stock in ProAssurance Corporation (PRA), an Alabama-based insurance holding company, emphasizing its strong track record, robust earnings, and market-beating performance. The author highlights ProAssurance's organic and inorganic growth, its recent 52-week high, and analyst interest. The piece also provides updates on other recommended stocks like iShares MSCI Emerging Markets (EEM), The TJX Companies, Inc. (TJX), Drew Industries Incorporated (DW), B&G Foods Inc. (BGS), ABM Industries Incorporated (ABM), and Cirrus Logic, Inc. (CRUS).
Dimensional Fund Advisors (PRA) reports 1.44M shares; 2.8% stake
Dimensional Fund Advisors has reported a 2.8% stake in ProAssurance Corp (PRA), totaling 1,442,782 shares through a Schedule 13G/A filing. While Dimensional disclaims direct beneficial ownership, stating the shares are held by affiliated Funds, it retains sole voting power over 1,411,907 shares. This disclosure indicates a passive investment approach, with the filing providing transparency on the total holdings and voting power managed by Dimensional.
ProAssurance (NYSE: PRA) details executive pay, incentives and merger progress
ProAssurance (NYSE: PRA) has filed an amendment to its annual report, providing updated information on executive compensation, director details, ownership, and merger progress. The company notes that 77% of its CEO's 2026 target compensation is "at risk" and that 2025 executive annual incentives were above target, despite 2023-2025 performance shares yielding no payout due to missed goals. Most regulatory approvals for its merger with The Doctors Company have been received, with an anticipated closing by June 30, 2026.
Assessing ProAssurance (PRA) Valuation As Shares Hold Steady And Growth Expectations Moderate
ProAssurance (PRA) has seen steady share prices and mixed long-term returns, prompting investors to question its valuation. Analysts see the company as modestly overvalued with a fair value of US$22.67, anticipating revenue contraction but improved profit margins in the coming years. The valuation narrative highlights a trade-off between slower revenue growth and richer margins, underpinned by potential risks from legal costs and competitive pricing.
PRA Financials: Revenue Breakdown, Margins & Competitor Comparison
This article provides a financial overview of ProAssurance Corp (PRA), detailing its profitability margins and comparing it to competitors like SAFT and UVE. It highlights PRA's operating margin of 20.19%, net margin of 12.23%, and a Return on Equity of 3.99%. The company maintains a leading market position with a market capitalization of $1.26 billion.
JPMorgan Chase & Co. Purchases 58,382 Shares of ProAssurance Corporation $PRA
JPMorgan Chase & Co. increased its stake in ProAssurance Corporation (NYSE:PRA) by 58.7% in the third quarter, acquiring an additional 58,382 shares to own a total of 157,891 shares valued at $3.79 million. Other institutional investors also boosted their positions, with overall institutional ownership in ProAssurance now at 85.58%. ProAssurance recently reported strong earnings, beating analyst estimates for both EPS and revenue, though revenue saw a 7.1% year-over-year decline.
ProAssurance (NYSE:PRA) Stock Rating Lowered by Wall Street Zen
Wall Street Zen has downgraded ProAssurance (NYSE:PRA) from a "hold" to a "sell" rating, despite the company exceeding Q4 earnings and revenue estimates. While other analysts have rated PRA differently, the MarketBeat consensus remains "Hold" with a target price of $25.00. Institutional investors have significantly increased their stakes in the company, which specializes in professional liability coverage for healthcare providers.
PRA SEC Filings - Proassurance Cp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for investors to access ProAssurance Corporation's (Ticker: PRA) SEC filings, including 10-K, 10-Q, and 8-K forms. It details the company's financial condition, segment performance, governance, and recent material events, particularly concerning its pending merger with The Doctors Company. The platform offers AI-powered summaries, impact scoring, and sentiment analysis for these regulatory documents.
Precision Trading with Proassurance Corporation (PRA) Risk Zones
This article provides a detailed AI-driven analysis for Proassurance Corporation (NYSE: PRA), identifying neutral sentiment across all time horizons and suggesting a wait-and-see approach. It outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis also highlights an exceptional 4.1:1 risk-reward short setup.
Vanguard disaggregates ProAssurance holdings (NYSE: PRA) — 0 shares reported
Vanguard has filed an amended Schedule 13G/A for ProAssurance Corp (NYSE: PRA), reporting zero beneficial ownership of common stock. This change is due to an internal realignment within Vanguard, where certain subsidiaries now report their holdings separately, as per SEC Release No. 34-39538. The filing indicates that The Vanguard Group itself no longer holds voting or dispositive power over any ProAssurance shares.
ProAssurance stock hits 52-week high at $24.78
ProAssurance Corp. (PRA) stock has hit a new 52-week high of $24.78, reflecting a positive trend and a 6.39% total return over the past year. Despite achieving this milestone and showing profitability, InvestingPro analysis suggests the stock may be overvalued relative to its Fair Value. The insurance company's performance is driven by strategic initiatives and favorable market conditions, attracting strong investor confidence.
ProAssurance stock hits 52-week high at $24.78 By Investing.com
ProAssurance (PRA) stock reached a new 52-week high of $24.78, currently trading at $24.79 with a market capitalization of $1.27 billion. The company has shown a 6.39% total return over the past year and has been profitable, though InvestingPro analysis suggests it may be overvalued relative to its Fair Value. This milestone reflects strong investor confidence and strategic execution by the company.
ProAssurance Corporation (NYSE:PRA) Given Consensus Recommendation of "Hold" by Brokerages
Six brokerages have issued a "Hold" consensus rating for ProAssurance Corporation (NYSE:PRA), with an average 1-year price target of $25.00. The company recently reported strong quarterly earnings, significantly beating EPS and revenue estimates, although revenue was down year-over-year. ProAssurance is currently trading near its 1-year high with substantial institutional ownership.
Hudson Bay Capital Management LP Raises Stock Position in ProAssurance Corporation $PRA
Hudson Bay Capital Management LP significantly increased its stake in ProAssurance Corporation (NYSE:PRA) by 1,050.0% in the third quarter, acquiring an additional 525,000 shares to own 575,000 shares worth $13.79 million. Other hedge funds, including Qube Research & Technologies Ltd, Hsbc Holdings PLC, Alliancebernstein L.P., Man Group plc, and Magnetar Financial LLC, also modified their holdings, with institutional investors owning 85.58% of the company's stock. ProAssurance recently reported strong earnings, exceeding consensus estimates, and analysts currently have a "Hold" rating on the stock with a consensus target price of $25.00.
Magnetar Financial Increases Stake in ProAssurance
Magnetar Financial LLC has increased its stake in ProAssurance Corporation (NYSE:PRA) by 2.3% during the third quarter, acquiring an additional 69,365 shares. This expands their total holdings to 3,026,173 shares, valued at $72.6 million, representing approximately 5.89% of the insurance provider's stock. The move highlights continued institutional confidence in ProAssurance's long-term prospects.
Magnetar Financial LLC Purchases 69,365 Shares of ProAssurance Corporation $PRA
Magnetar Financial LLC increased its holdings in ProAssurance Corporation (NYSE:PRA) by 2.3% during the third quarter, acquiring an additional 69,365 shares to own a total of 3,026,173 shares valued at approximately $72.6 million. This investment now represents about 0.4% of Magnetar's portfolio, making ProAssurance its 17th largest holding. ProAssurance recently outperformed earnings estimates, reporting an EPS of $0.82 against an expected $0.22, with revenues of $269.6 million.
What ProAssurance (PRA)'s Profit Jump Amid Lower Revenue Means For Shareholders
ProAssurance (PRA) reported a significant net income increase in Q4 2025 despite lower revenue, suggesting improved underwriting and cost controls are positively impacting earnings quality. While full-year 2025 revenue and EPS were slightly softer, the recent quarterly performance strengthens the thesis that disciplined management can enhance profitability even with top-line pressure. Investors are advised to monitor potential risks like rising claims severity and legal costs, though the company's long-term forecasts project earnings growth despite a revenue decline.
ProAssurance Corp stock hits 52-week high at 24.7 USD
ProAssurance Corp (PRA) stock has reached a new 52-week high of $24.70 USD, reflecting a 57.31% increase over the past year. The company has a market capitalization of $1.27 billion and a P/E ratio of 24.9, indicating strong investor confidence. Despite a "GOOD" financial health score, InvestingPro data suggests the stock might be overvalued relative to its Fair Value.
ProAssurance Stock Hits New 52-Week High
ProAssurance Corporation (NYSE:PRA) reached a new 52-week high of $24.71, closing at $24.59. This performance indicates market optimism despite mixed analyst ratings from Wall Street Zen (Hold), Zacks Research (Strong-Buy), and Weiss Ratings (Hold), with an overall consensus rating of "Hold" and a $25.00 price target. Investors are closely monitoring the company's financial health and future analyst updates.
ProAssurance Corp stock hits 52-week high at 24.7 USD
ProAssurance Corp (PRA) has reached a new 52-week high of $24.70, reflecting significant investor confidence and a 57.31% increase in stock price over the past year. The company has a market capitalization of $1.27 billion and a P/E ratio of 24.9, but InvestingPro suggests it may be overvalued despite a "GOOD" financial health score. Additional insights and analysis for PRA and other equities are available through InvestingPro Tips and comprehensive research reports.
ProAssurance Corporation Liability Coverage Model Gains NYSE Composite Attention
ProAssurance (NYSE:PRA) specializes in providing professional liability insurance to healthcare professionals, including physicians and medical institutions, and its market activities are drawing attention on the NYSE Composite. The article highlights the company's role in the specialized insurance sector and its relevance within broader financial markets. It also mentions that underwriting is crucial for ProAssurance, as it helps evaluate risk based on medical specialty and practice environment.
ProAssurance (NYSE:PRA) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen has upgraded ProAssurance (NYSE:PRA) from a "sell" to a "hold" rating, contributing to a consensus "Hold" rating and a $25.00 price target from analysts. The insurance provider recently reported strong quarterly earnings of $0.82 EPS, significantly beating estimates, and revenues of $269.6 million, though revenue was down year-over-year. Institutional investors hold a substantial portion of the stock, with several increasing their positions.
ProAssurance (PRA) executive converts RSUs and withholds shares for taxes
Kevin Merrick Shook, President of a ProAssurance (PRA) subsidiary, converted several Restricted Share Units (RSUs) into common stock on February 25, 2026, and simultaneously disposed of 7,587 shares to cover tax obligations. After these transactions, he directly held 53,447 shares of ProAssurance common stock. The RSUs, issued under the 2014 Equity Incentive Compensation Plan, vest in one-third increments over three years and accelerate under specific conditions like death, disability, or a qualifying "Good Reason" termination, with the cash portion covering federal, state, and local taxes.
Assessing ProAssurance (PRA) Valuation After Strong One Year Shareholder Returns
ProAssurance (PRA) has drawn investor attention due to its substantial one-year shareholder return of nearly 59%. Despite this strong performance and trading close to analyst price targets, the company is assessed as "8.4% Overvalued" with a narrative fair value of $22.67 compared to its closing price of $24.56. This valuation is influenced by expected future profitability improvements from renewal premium increases and re-underwriting efforts, alongside risks such as persistent legal cost pressures.
ProAssurance (NYSE: PRA) executive exercises RSUs and withholds shares for taxes
ProAssurance Corporation executive Robert David Francis exercised Restricted Stock Units on February 25, 2026, receiving 3,226, 8,765, and 5,890 shares of common stock at $24.47 per share. To cover tax obligations, 7,711 shares were disposed of. After these transactions, Francis directly holds 31,196 common shares and various tranches of RSUs vesting through 2029 under the company’s equity incentive plans.
